PubMed:10195428
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-40 | protein | denotes | Epstein-Barr virus nuclear antigen 2 |
| T2 | 42-47 | protein | denotes | EBNA2 |
| T3 | 73-85 | cell_type | denotes | B lymphocyte |
| T4 | 128-145 | protein | denotes | type I interferon |
| T5 | 149-178 | cell_line | denotes | Burkitt's lymphoma cell lines |
| T6 | 180-216 | protein | denotes | Epstein-Barr virus nuclear antigen 2 |
| T7 | 218-223 | protein | denotes | EBNA2 |
| T8 | 310-328 | protein | denotes | type I interferons |
| T9 | 330-344 | protein | denotes | IFN-alpha/beta |
| T10 | 403-408 | protein | denotes | EBNA2 |
| T11 | 431-434 | protein | denotes | IFN |
| T12 | 447-476 | cell_line | denotes | Burkitt's lymphoma cell lines |
| T13 | 492-497 | protein | denotes | EBNA2 |
| T14 | 570-590 | DNA | denotes | IFN-stimulated genes |
| T15 | 592-596 | DNA | denotes | ISGs |
| T16 | 632-641 | DNA | denotes | promoters |
| T17 | 653-691 | DNA | denotes | interferon-stimulated response element |
| T18 | 693-697 | DNA | denotes | ISRE |
| T19 | 706-738 | DNA | denotes | gamma interferon activation site |
| T20 | 740-743 | DNA | denotes | GAS |
| T21 | 818-822 | DNA | denotes | ISGs |
| T22 | 839-844 | protein | denotes | EBNA2 |
| T23 | 982-987 | protein | denotes | EBNA2 |
| T24 | 1036-1059 | DNA | denotes | RBP-Jkappa binding site |
| T25 | 1100-1105 | protein | denotes | EBNA2 |
| T26 | 1116-1121 | protein | denotes | EBNA2 |
| T27 | 1165-1182 | DNA | denotes | IFN-beta promoter |
| T28 | 1195-1232 | cell_line | denotes | EBV-negative Burkitt's lymphoma cells |
| T29 | 1256-1265 | DNA | denotes | EBV genes |
| T30 | 1305-1313 | protein | denotes | IFN-beta |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 10195428-2#84#87#gene3439 | 431-434 | gene3439 | denotes | IFN |
| 10195428-2#84#87#gene3447 | 431-434 | gene3447 | denotes | IFN |
| 10195428-2#100#118#diseaseC0006413 | 447-465 | diseaseC0006413 | denotes | Burkitt's lymphoma |
| 10195428-6#49#57#gene3456 | 1165-1173 | gene3456 | denotes | IFN-beta |
| 10195428-6#92#110#diseaseC0006413 | 1208-1226 | diseaseC0006413 | denotes | Burkitt's lymphoma |
| 84#87#gene3439100#118#diseaseC0006413 | 10195428-2#84#87#gene3439 | 10195428-2#100#118#diseaseC0006413 | associated_with | IFN,Burkitt's lymphoma |
| 84#87#gene3447100#118#diseaseC0006413 | 10195428-2#84#87#gene3447 | 10195428-2#100#118#diseaseC0006413 | associated_with | IFN,Burkitt's lymphoma |
| 49#57#gene345692#110#diseaseC0006413 | 10195428-6#49#57#gene3456 | 10195428-6#92#110#diseaseC0006413 | associated_with | IFN-beta,Burkitt's lymphoma |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-179 | Sentence | denotes | The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines. |
| S2 | 180-346 | Sentence | denotes | Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein involved in cell transformation, interferes with the cellular response to type I interferons (IFN-alpha/beta). |
| S3 | 347-477 | Sentence | denotes | We investigated the function of conditionally expressed EBNA2 in the context of the IFN response in Burkitt's lymphoma cell lines. |
| S4 | 478-745 | Sentence | denotes | Expression of EBNA2 led to the transcriptional activation of both endogenous or transfected IFN-stimulated genes (ISGs), genes which contain within their promoters either the interferon-stimulated response element (ISRE) or the gamma interferon activation site (GAS). |
| S5 | 746-936 | Sentence | denotes | In search of a molecular mechanism for the transcriptional induction of ISGs, we observed an EBNA2-dependent synthesis of IFN-beta mRNA at low levels and the secretion of low amounts of IFN. |
| S6 | 937-1115 | Sentence | denotes | A transfected IFN-beta promoter responded to EBNA2 activation, and a sequence closely resembling a RBP-Jkappa binding site was pinpointed as a potential target of EBNA2 activity. |
| S7 | 1116-1324 | Sentence | denotes | EBNA2-dependent transcriptional induction of the IFN-beta promoter occurred in EBV-negative Burkitt's lymphoma cells, indicating that other EBV genes were not required for the induction of IFN-beta synthesis. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-48 | NP | denotes | The Epstein-Barr virus nuclear antigen 2 (EBNA2) |
| C2 | 50-101 | NP | denotes | a protein required for B lymphocyte immortalization |
| C3 | 149-178 | NP | denotes | Burkitt's lymphoma cell lines |
| C4 | 180-224 | NP | denotes | Epstein-Barr virus nuclear antigen 2 (EBNA2) |
| C5 | 226-267 | NP | denotes | a protein involved in cell transformation |
| C6 | 447-476 | NP | denotes | Burkitt's lymphoma cell lines |
| C7 | 492-497 | NP | denotes | EBNA2 |
| C8 | 539-597 | NP | denotes | both endogenous or transfected IFN-stimulated genes (ISGs) |
| C10 | 599-604 | NP | denotes | genes |
| C11 | 605-610 | NP | denotes | which |
| C12 | 626-631 | NP | denotes | their |
| C9 | 599-744 | NP | denotes | genes which contain within their promoters either the interferon-stimulated response element (ISRE) or the gamma interferon activation site (GAS) |
| C13 | 818-822 | NP | denotes | ISGs |
| C14 | 937-968 | NP | denotes | A transfected IFN-beta promoter |
| C15 | 1161-1182 | NP | denotes | the IFN-beta promoter |
| R1 | C2 | C1 | coref-appos | a protein required for B lymphocyte immortalization,The Epstein-Barr virus nuclear antigen 2 (EBNA2) |
| R2 | C4 | C1 | coref-ident | Epstein-Barr virus nuclear antigen 2 (EBNA2),The Epstein-Barr virus nuclear antigen 2 (EBNA2) |
| R3 | C5 | C4 | coref-appos | a protein involved in cell transformation,Epstein-Barr virus nuclear antigen 2 (EBNA2) |
| R4 | C6 | C3 | coref-ident | Burkitt's lymphoma cell lines,Burkitt's lymphoma cell lines |
| R5 | C7 | C4 | coref-ident | EBNA2,Epstein-Barr virus nuclear antigen 2 (EBNA2) |
| R6 | C11 | C10 | coref-relat | which,genes |
| R7 | C12 | C8 | coref-pron | their,both endogenous or transfected IFN-stimulated genes (ISGs) |
| R8 | C9 | C8 | coref-appos | genes which contain within their promoters either the interferon-stimulated response element (ISRE) or the gamma interferon activation site (GAS),both endogenous or transfected IFN-stimulated genes (ISGs) |
| R9 | C13 | C9 | coref-ident | ISGs,genes which contain within their promoters either the interferon-stimulated response element (ISRE) or the gamma interferon activation site (GAS) |
| R10 | C15 | C14 | coref-ident | the IFN-beta promoter,A transfected IFN-beta promoter |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-22 | virus | denotes | Epstein-Barr virus |
| T2 | 42-47 | protein_molecule | denotes | EBNA2 |
| T3 | 73-85 | cell_type | denotes | B lymphocyte |
| T4 | 128-145 | protein_family_or_group | denotes | type I interferon |
| T5 | 149-178 | cell_line | denotes | Burkitt's lymphoma cell lines |
| T6 | 180-198 | virus | denotes | Epstein-Barr virus |
| T7 | 218-223 | protein_molecule | denotes | EBNA2 |
| T8 | 310-328 | protein_family_or_group | denotes | type I interferons |
| T9 | 330-344 | protein_family_or_group | denotes | IFN-alpha/beta |
| T10 | 403-408 | protein_molecule | denotes | EBNA2 |
| T11 | 431-434 | protein_family_or_group | denotes | IFN |
| T12 | 447-476 | cell_line | denotes | Burkitt's lymphoma cell lines |
| T13 | 492-497 | protein_molecule | denotes | EBNA2 |
| T14 | 509-535 | other_name | denotes | transcriptional activation |
| T15 | 570-590 | DNA_family_or_group | denotes | IFN-stimulated genes |
| T16 | 592-596 | DNA_family_or_group | denotes | ISGs |
| T17 | 632-641 | DNA_domain_or_region | denotes | promoters |
| T18 | 653-691 | DNA_domain_or_region | denotes | interferon-stimulated response element |
| T19 | 693-697 | DNA_domain_or_region | denotes | ISRE |
| T20 | 706-738 | DNA_domain_or_region | denotes | gamma interferon activation site |
| T21 | 740-743 | DNA_domain_or_region | denotes | GAS |
| T22 | 789-814 | other_name | denotes | transcriptional induction |
| T23 | 818-822 | DNA_family_or_group | denotes | ISGs |
| T24 | 839-844 | protein_molecule | denotes | EBNA2 |
| T25 | 982-987 | protein_molecule | denotes | EBNA2 |
| T26 | 1036-1059 | DNA_domain_or_region | denotes | RBP-Jkappa binding site |
| T27 | 1100-1105 | protein_molecule | denotes | EBNA2 |
| T28 | 1116-1121 | protein_molecule | denotes | EBNA2 |
| T29 | 1132-1157 | other_name | denotes | transcriptional induction |
| T30 | 1165-1182 | DNA_domain_or_region | denotes | IFN-beta promoter |
| T31 | 1195-1232 | cell_line | denotes | EBV-negative Burkitt's lymphoma cells |
| T32 | 1256-1265 | DNA_family_or_group | denotes | EBV genes |
| T33 | 1305-1313 | protein_molecule | denotes | IFN-beta |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 431-434 | gene:3439 | denotes | IFN |
| T1 | 457-465 | disease:C0024299 | denotes | lymphoma |
| T2 | 431-434 | gene:3447 | denotes | IFN |
| T3 | 457-465 | disease:C0024299 | denotes | lymphoma |
| R1 | T0 | T1 | associated_with | IFN,lymphoma |
| R2 | T2 | T3 | associated_with | IFN,lymphoma |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 447-465 | HP_0030080 | denotes | Burkitt's lymphoma |
| T2 | 457-465 | HP_0002665 | denotes | lymphoma |
| T3 | 1208-1226 | HP_0030080 | denotes | Burkitt's lymphoma |
| T4 | 1218-1226 | HP_0002665 | denotes | lymphoma |